These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7819582)

  • 61. Ductal carcinoma in situ of the breast: the importance of morphologic and molecular interactions.
    Mardekian SK; Bombonati A; Palazzo JP
    Hum Pathol; 2016 Mar; 49():114-23. PubMed ID: 26826418
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Loss of aurora A/STK15/BTAK overexpression correlates with transition of in situ to invasive ductal carcinoma of the breast.
    Hoque A; Carter J; Xia W; Hung MC; Sahin AA; Sen S; Lippman SM
    Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1518-22. PubMed ID: 14693746
    [TBL] [Abstract][Full Text] [Related]  

  • 63. P53 and C-erbb-2 alterations in in-situ and invasive ductal breast carcinomas - a genetic and immunohistochemical analysis.
    Marchetti A; Buttitta F; Pellegrini S; Campani D; Cecchetti D; Bistocchi M
    Int J Oncol; 1995 Aug; 7(2):343-7. PubMed ID: 21552845
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Ductal epithelial proliferations of the breast: a biological continuum? Comparative genomic hybridization and high-molecular-weight cytokeratin expression patterns.
    Boecker W; Buerger H; Schmitz K; Ellis IA; van Diest PJ; Sinn HP; Geradts J; Diallo R; Poremba C; Herbst H
    J Pathol; 2001 Nov; 195(4):415-21. PubMed ID: 11745672
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Characterization of extensive genetic alterations in ductal carcinoma in situ by fluorescence in situ hybridization and molecular analysis.
    Murphy DS; Hoare SF; Going JJ; Mallon EE; George WD; Kaye SB; Brown R; Black DM; Keith WN
    J Natl Cancer Inst; 1995 Nov; 87(22):1694-704. PubMed ID: 7473818
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Long term clinical follow-up of atypical ductal hyperplasia and lobular carcinoma in situ in breast core needle biopsies.
    Renshaw AA; Gould EW
    Pathology; 2016 Jan; 48(1):25-9. PubMed ID: 27020205
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Quantitative analysis of allele imbalance supports atypical ductal hyperplasia lesions as direct breast cancer precursors.
    Larson PS; de las Morenas A; Cerda SR; Bennett SR; Cupples LA; Rosenberg CL
    J Pathol; 2006 Jul; 209(3):307-16. PubMed ID: 16604511
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Molecular mechanisms of breast cancer progression: lessons from mouse mammary cancer models and gene expression profiling.
    Ye Y; Qiu TH; Kavanaugh C; Green JE
    Breast Dis; 2004; 19():69-82. PubMed ID: 15687699
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [External quality control of immunohistochemical studies in pathomorphology: tasks, problems, solutions, development prospects].
    Zavalishina LÉ; Vasilyeva AI; Kuznetsova OA; Skrypnikova KA; Frank GA
    Arkh Patol; 2023; 85(2):48-52. PubMed ID: 37053354
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Prognostic value of molecular markers and cytogenetic alterations that characterize breast cancer precursor lesions (Review).
    DI Bonito M; Cantile M; DE Cecio R; Liguori G; Botti G
    Oncol Lett; 2013 Nov; 6(5):1181-1183. PubMed ID: 24179491
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Molecular and immunohistochemical analysis of p53 mutations in scrapings and tissue from preinvasive and invasive breast cancer.
    Lisboa BW; Vogtländer S; Gilster T; Riethdorf L; Milde-Langosch K; Löning T
    Virchows Arch; 1997 Dec; 431(6):375-81. PubMed ID: 9428925
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Relationship between p53 expression and other prognostic factors in human breast carcinoma. An immunohistochemical study.
    Martinazzi M; Crivelli F; Zampatti C; Martinazzi S
    Am J Clin Pathol; 1993 Sep; 100(3):213-7. PubMed ID: 8379528
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Nuclear accumulation of p53 protein correlates with mutations in the p53 gene on archival paraffin-embedded tissues of human breast cancer.
    Umekita Y; Kobayashi K; Saheki T; Yoshida H
    Jpn J Cancer Res; 1994 Aug; 85(8):825-30. PubMed ID: 7928628
    [TBL] [Abstract][Full Text] [Related]  

  • 74. p53 gain-of-function mutation in codon 175 is a rare event in human breast cancer.
    Runnebaum IB; Kieback DG; Tong XW; Kreienberg R
    Hum Mol Genet; 1993 Sep; 2(9):1501-2. PubMed ID: 7902164
    [No Abstract]   [Full Text] [Related]  

  • 75. The value of imaging combined with clinicopathological features in the diagnosis of high-risk breast lesions.
    Zhou J; Sun S; Lin L; Jiang T; Hu X; Gu Y; You C
    Gland Surg; 2022 Aug; 11(8):1323-1332. PubMed ID: 36082087
    [TBL] [Abstract][Full Text] [Related]  

  • 76. HER2 and β-catenin protein location: importance in the prognosis of breast cancer patients and their correlation when breast cancer cells suffer stressful situations.
    Cuello-Carrión FD; Shortrede JE; Alvarez-Olmedo D; Cayado-Gutiérrez N; Castro GN; Zoppino FC; Guerrero M; Martinis E; Wuilloud R; Gómez NN; Biaggio V; Orozco J; Gago FE; Ciocca LA; Fanelli MA; Ciocca DR
    Clin Exp Metastasis; 2015 Feb; 32(2):151-68. PubMed ID: 25636904
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Intraductal proliferative lesions of the breast-terminology and biology matter: premalignant lesions or preinvasive cancer?
    Costarelli L; Campagna D; Mauri M; Fortunato L
    Int J Surg Oncol; 2012; 2012():501904. PubMed ID: 22655184
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Expression of HER2 and bradykinin B₁ receptors in precursor lesions of gallbladder carcinoma.
    Toledo C; Matus CE; Barraza X; Arroyo P; Ehrenfeld P; Figueroa CD; Bhoola KD; Del Pozo M; Poblete MT
    World J Gastroenterol; 2012 Mar; 18(11):1208-15. PubMed ID: 22468084
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The influence of clinicopathological features on the predictive accuracy of conventional breast imaging in determining the extent of screen-detected high-grade pure ductal carcinoma in situ.
    Hayward L; Oeppen RS; Grima AV; Royle GT; Rubin CM; Cutress RI
    Ann R Coll Surg Engl; 2011 Jul; 93(5):385-90. PubMed ID: 21943463
    [TBL] [Abstract][Full Text] [Related]  

  • 80. HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion.
    Korkaya H; Paulson A; Iovino F; Wicha MS
    Oncogene; 2008 Oct; 27(47):6120-30. PubMed ID: 18591932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.